At a time when cancer is spreading at a disturbingly fast pace across the globe, an Isreali biotech company have claimed that they will have the cure for this deadly disease by 2020. 

Although different types of treatments are available in the market, but nothing promises to cure this deadly disease 100%. But Accelerated Evolution Biotechnologies Ltd (AEBi), founded in 2000 from the ITEK Weizmann technology incubator has made bold claims to cure the disease completely. 

In an interview to a leading daily, Aridor, chairman of the board of AEBi, has asserted that their cancer cure will be effective from the very first day and will last for a few weeks. Additionally, their medicines will have “no or minimal side-effects”. He further said that the cure for cancer will be available at a much lower cost than other treatments available in the market. 

The treatment which the biotech company calls MuTaTo (multi-target toxin) is based on SoAP technology, which belongs to the phage display group of technologies. 

CEO of the biotech company Dr Ilan Morad said they started with identifying why other cancer-related drugs and treatment are not working and then they looked for an effective way to counter it. 

Most cancer drugs attack a specific target or on the cancer cell, but MuTaTo attacks the cancer cell’s receptors from three different directions.

Original Source

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.